Dr. Rasha Kelej, CEO of Merck Foundation with Prof. Dr. Hatem Ahmed Aboulkassem, Dean of National Cancer Institute (on her left), Prof. Abdel-Rahman Zekri, Vice Dean of National Cancer Institute (on her right) and Alumni from Ghana, Namibia, Liberia and R
Dr. Rasha Kelej, CEO of Merck Foundation entering the National Cancer Institute along with alumni students from Ghana, Namibia, Liberia and Rwanda, registered with the Master Degree program in Medical Oncology under Merck Cancer Access Program
Dr. Rasha Kelej, CEO of Merck Foundation entering the National Cancer Institute along with alumni students from Ghana, Namibia, Liberia and Rwanda, registered with the Master Degree program in Medical Oncology under Merck Cancer Access Program
Dr. Rasha Kelej, CEO of Merck Foundation with Prof. Dr. Hatem Ahmed Aboulkassem, Dean of National Cancer Institute (on her left), Prof. Abdel-Rahman Zekri, Vice Dean of National Cancer Institute (on her right) and Alumni from Ghana, Namibia, Liberia and R
Dr. Rasha Kelej, CEO of Merck Foundation with Prof. Dr. Hatem Ahmed Aboulkassem, Dean of National Cancer Institute, Prof. Abdel-Rahman Zekri, Vice Dean of National Cancer Institute during the meeting.
Dr. Rasha Kelej, CEO of Merck Foundation entering the National Cancer Institute along with alumni students from Ghana, Namibia, Liberia and Rwanda, registered with the Master Degree program in Medical Oncology under Merck Cancer Access Program
Dr. Rasha Kelej, CEO of Merck Foundation entering the National Cancer Institute along with alumni students from Ghana, Namibia, Liberia and Rwanda, registered with the Master Degree program in Medical Oncology under Merck Cancer Access Program
Dr. Rasha Kelej, CEO of Merck Foundation entering the National Cancer Institute along with alumni students from Ghana, Namibia, Liberia and Rwanda, registered with the Master Degree program in Medical Oncology under Merck Cancer Access Program
